Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Amy Allen

Physician Assistant Frisco, TX Physician Assistant

NPI 1962006304 CMS profile 10925078

11500 State Highway 121 Ste 930, Frisco, TX 75035

Open in the dashboard

General payments

$14,453

865 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Amy Allen of Frisco, TX is reported in the CMS Open Payments database as having received $14,453 across 865 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,707 217
2024 General $3,315 197
2023 General $3,063 169
2022 General $2,161 129
2021 General $2,207 153

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Amy Allen
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Amy Allen were reported at $3,707. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Amy Allen Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $2,207 $132 $37–$438 $132
2022 $2,161 $155 $48–$522 $149
2023 $3,063 $167 $52–$557 $160
2024 $3,315 $178 $55–$600 $164
2025 $3,707 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Janssen Pharmaceuticals, Inc $1,880 137 payments
  2. AbbVie, Inc. $1,572 111 payments
  3. ITI, Inc. $1,403 67 payments
  4. Otsuka America Pharmaceutical, Inc. $1,149 75 payments
  5. Neurocrine Biosciences, Inc. $1,126 57 payments
  6. Teva Pharmaceuticals USA, Inc. $870 44 payments
  7. Corium, Inc. $785 34 payments
  8. Lundbeck LLC $640 43 payments
  9. Alkermes, Inc. $604 27 payments
  10. Sunovion Pharmaceuticals Inc. $480 38 payments
  11. Other $3,942 232 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $14,334 861 payments
  2. Education $119 4 payments
Products named General payments · program years 2021–2025
  1. SPRAVATO $1,361 113 payments
  2. VRAYLAR Neuroscience $1,091 82 payments
  3. CAPLYTA $1,019 50 payments
  4. INGREZZA $901 46 payments
  5. REXULTI Psychiatry $886 60 payments
  6. Azstarys $785 34 payments
  7. INVEGA SUSTENNA $760 34 payments
  8. REXULTI Psychiatry $640 43 payments
  9. VRAYLAR Neuroscience $481 29 payments
  10. LATUDA $473 37 payments
  11. Other $8,931 474 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 25 drugs

Part D claims

676

Median for Physician Assistant: 241

Drug cost

$236,768

Median for Physician Assistant: $4,110

Branded share of claims

14.3%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ingrezza Valbenazine Tosylate Brand 26 $222,964
Loreev Xr Lorazepam Brand 11 $4,593
Lurasidone Hcl Generic 17 $3,478
Vilazodone Hcl Generic 15 $1,293
Duloxetine Hcl Generic 42 $895
Buspirone Hcl Generic 38 $629
Doxepin Hcl Generic 16 $310
Gabapentin Generic 20 $294
Clonazepam Generic 97 $266
Quetiapine Fumarate Generic 40 $245

The 10 drugs with the highest cost, of 25 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 5 billing codes

Paid by Medicare

$8,686

Medicare's payments for the services billed

Medicare patients

16

Average age 50

Services billed

182

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Depression 75%
Heart failure 0%
Ischemic heart disease 0%
COPD 0%
Osteoporosis 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 29 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
REXULTI
  • Otsuka America Pharmaceutical, Inc. $223
  • Lundbeck LLC $187
$410 — —
VRAYLAR
  • AbbVie, Inc. $353
$353 — —
CAPLYTA
  • ITI, Inc. $253
$253 — —
SPRAVATO
  • Janssen Pharmaceuticals, Inc $227
$227 — —
INVEGA SUSTENNA
  • Janssen Pharmaceuticals, Inc $180
  • Janssen Scientific Affairs, LLC $43
$223 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See more in the dashboard: 25 with a free account, all 29 with Patron

Records

865 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record